Spontaneous intramural small bowel hematoma in a patient with acute myeloid leukaemia receiving chemotherapy and nilotinib

Glenda M. Delgado Ramos, Guilherme Piovezani Ramos, Thomas G. Cotter

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Spontaneous intramural small bowel hematoma (SISBH) is a rare, acute abdominal condition, with increasing incidence in recent years. Excessive anticoagulation with vitamin K antagonists is the most common aetiology. We report the case of a large acute jejunal intramural hematoma in a patient with newly diagnosed acute myeloid leukaemia receiving chemotherapy and nilotinib. The patient presented with abdominal pain, haematochezia, acute anaemia and thrombocytopenia. CT of the abdomen and pelvis revealed SISBH. The patient was managed conservatively with supportive management and cessation of nilotinib therapy. The patient's symptoms improved, with subsequent CT imaging confirming resolution. This case highlights an uncommon cause of gastrointestinal bleed usually diagnosed only after radiological imaging. A correct diagnosis is important as SISBH usually responds to conservative measures, and may obviate the patient from unnecessary invasive investigations.

Original languageEnglish (US)
Article number220439
JournalBMJ Case Reports
Volume2017
DOIs
StatePublished - 2017
Externally publishedYes

Keywords

  • chemotherapy
  • gi bleeding
  • haematology (incl blood transfusion)
  • unwanted effects/adverse reactions

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Spontaneous intramural small bowel hematoma in a patient with acute myeloid leukaemia receiving chemotherapy and nilotinib'. Together they form a unique fingerprint.

Cite this